Shares of Alcentra Capital Corp. (NASDAQ:ABDC) have earned a consensus recommendation of “Hold” from the eight brokerages that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $13.50.

A number of equities research analysts recently commented on the stock. Raymond James Financial, Inc. downgraded shares of Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and reduced their price objective for the company from $16.00 to $14.00 in a research report on Monday, July 17th. DA Davidson assumed coverage on shares of Alcentra Capital Corp. in a research report on Wednesday, July 5th. They issued a “buy” rating and a $15.00 price objective for the company. Keefe, Bruyette & Woods restated a “hold” rating and issued a $14.00 price objective on shares of Alcentra Capital Corp. in a research report on Tuesday, July 25th. TheStreet downgraded shares of Alcentra Capital Corp. from a “b” rating to a “c+” rating in a research report on Monday, July 24th. Finally, ValuEngine downgraded shares of Alcentra Capital Corp. from a “buy” rating to a “hold” rating in a research report on Friday, September 1st.

In related news, Director Steven H. Reiff bought 11,668 shares of the company’s stock in a transaction on Monday, August 7th. The stock was bought at an average cost of $10.72 per share, with a total value of $125,080.96. Following the completion of the acquisition, the director now owns 7,000 shares in the company, valued at approximately $75,040. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 4.96% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. Muzinich & Co. Inc. increased its stake in shares of Alcentra Capital Corp. by 34.7% during the 2nd quarter. Muzinich & Co. Inc. now owns 610,164 shares of the asset manager’s stock worth $8,292,000 after purchasing an additional 157,251 shares in the last quarter. UBS Group AG increased its stake in shares of Alcentra Capital Corp. by 20.7% during the 1st quarter. UBS Group AG now owns 258,940 shares of the asset manager’s stock worth $3,558,000 after purchasing an additional 44,387 shares in the last quarter. Raymond James Financial Services Advisors Inc. increased its stake in shares of Alcentra Capital Corp. by 45.6% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 242,865 shares of the asset manager’s stock worth $3,300,000 after purchasing an additional 76,115 shares in the last quarter. Confluence Investment Management LLC increased its stake in shares of Alcentra Capital Corp. by 2.7% during the 2nd quarter. Confluence Investment Management LLC now owns 209,528 shares of the asset manager’s stock worth $2,847,000 after purchasing an additional 5,566 shares in the last quarter. Finally, Salem Investment Counselors Inc. purchased a new position in shares of Alcentra Capital Corp. during the 2nd quarter worth approximately $646,000. 31.49% of the stock is owned by institutional investors and hedge funds.

The business also recently announced a quarterly dividend, which was paid on Thursday, October 5th. Shareholders of record on Saturday, September 30th were issued a $0.34 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $1.36 dividend on an annualized basis and a yield of 13.06%. Alcentra Capital Corp.’s dividend payout ratio (DPR) is presently -1,700.00%.

TRADEMARK VIOLATION WARNING: “Alcentra Capital Corp. (ABDC) Given Consensus Rating of “Hold” by Brokerages” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/13/alcentra-capital-corp-abdc-given-consensus-rating-of-hold-by-brokerages.html.

Alcentra Capital Corp. Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Analyst Recommendations for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.